Beike Biotechnology Upgrades Its Processing and Cryopreservation Technology to Expedite Advancements in Stem Cell Therapies
Beike and ThermoGenesis Intend to Establish a “Center of Excellence” Showcase in Taizhou City TAIZHOU, China, March 16, 2011 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd. (“Beike”) (https://www.beikebiotech.com), China’s leading stem…
ThermoGenesis Announces Agreement for AXP and BioArchive Cord Blood Systems With Major Chinese Stem Cell Company
RANCHO CORDOVA, Calif., Feb. 10, 2011 /PRNewswire/ — ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today it…
Beike Biotechnology and Medistem, Inc. Report on 114 Patients Treated With Novel Cord Blood Stem Cell Protocol; New Approach Opens Door to Expanded Uses of Cord Blood Stem Cells SHENZHEN,…
New Center Integrates Traditional Chinese, Romanian and Western Therapies CAMPINA and PRAHOVA, Romania, July 20 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd. (https://www.beikebiotech.com/index.php ), one of the world’s leading biotechnology companies…
Beike Biotech Launches New International Stem Cell Venture
“Beike Holdings Limited”, a Strategic Joint Venture With Bangkok-Based SiriCell Technologies, Inc., Will Support the Rapid Clinical Translation of Stem Cell Therapies & Regulatory Approval Outside of China SHENZHEN, China,…
Lupus study shows promising results using umbilical cord mesenchymal stem cells. NANJING, Jiangsu, China, June 7, 2010 /PRNewswire-Asia/ — A new study shows that umbilical cord mesenchymal stem cell transplant…